Industry

NEW YORK–(BUSINESS WIRE)–Allosteric Bioscience, Inc. (ABI), has announced today that it has licensed technology from Johns Hopkins University for the treatment or prevention of sarcopenia which is a serious medical condition involving the loss of muscle mass, quality, and strength and is a significant part of the natural aging process. Sarcopenia can result in reduced … [Read more…]

– ENCELTO is the First and Only FDA-approved Treatment for MacTel CUMBERLAND, R.I.–(BUSINESS WIRE)–Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, announced that the U.S. Food and Drug Administration (FDA), has approved ENCELTO™ (revakinagene taroretcel-lwey) for the treatment of Macular Telangiectasia type 2 (MacTel). MacTel is a … [Read more…]

Achieved record quarterly and full-year total revenue of $60M and $203M, growing 35% and 24% versus prior year Recorlev® revenue more than doubled versus prior year and grew 28% in the fourth quarter sequentially Ended Q4 with over $71M in cash, generating $2M in cash in the fourth quarter Provides full-year 2025 total revenue guidance … [Read more…]

CFO transition plan focusses on business continuity and the company’s strong growth trajectory as European leader in medical dermatology Jon U. Garay Alonso has over 25 years of experience in business and finance in numerous leadership roles with increasing seniority in the pharma industry and other sectors Mike McClellan will leave Almirall in September, after … [Read more…]

New QIAstat-Dx Gastrointestinal Panel 2 Mini B adds to QIAGEN’s growing U.S. menu for syndromic testing of gastrointestinal infections Panel delivers rapid detection of five common bacterial pathogens for outpatient use, aiding fast and informed treatment decisions QIAGEN building momentum in the U.S. syndromic testing market with six regulatory clearance of panels for use on … [Read more…]

AWS’s AI services and global infrastructure support the expansion of Philips’ healthcare informatics portfolio and product development for secure, interoperable, and data-driven healthcare SEATTLE–(BUSINESS WIRE)–Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), today announced that Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has selected AWS as its … [Read more…]

SASKATOON, Saskatchewan–(BUSINESS WIRE)–#Saskatchewan–Ag-West Bio Inc., a non-profit helping move research to market and grow bio-business in the province, is receiving $350,500 in non-repayable funding under the Regional Innovation Ecosystems (RIE) program to enhance food ingredient cluster capacity and programming in Saskatchewan. Prairie Food Link, Saskatchewan’s food ingredient processing cluster, has been operating as a network … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–#bestplacestowork–DeciBio has earned recognition in the most prominent rankings in its field: GenomeWeb, The Vault Consulting 50, and Management Consulted. GenomeWeb, a leading online news source for the life sciences industry, awarded DeciBio as the winner of its Best Places to Work Award in the 26-50 Employee category. Likewise, The Vault Consulting 50 … [Read more…]

MENLO PARK, Calif.–(BUSINESS WIRE)–MedaSystems, the leading SaaS platform for Expanded Access (EA) and Investigator-Initiated Studies (IIS), today announced additional funding from existing investors, Debiopharm Innovation Fund, Nina Capital, and Young Sohn, a co-founder of Veeva Systems. This investment underscores confidence in MedaSystems’ ability to modernize pre-approval access pathways through its AI-driven workflow platform. By streamlining … [Read more…]

Dr. Dolsten was most recently CSO of Pfizer and has served in leadership roles at AstraZeneca, Boehringer Ingelheim, Pharmacia, and Wyeth Pharmaceuticals Appointment follows the transition of Morten Graugaard from Chairperson to CEO earlier this year COPENHAGEN, Denmark–(BUSINESS WIRE)–Orbis Medicines, a leader in oral macrocycle drug discovery, today announces the appointment of Mikael Dolsten, M.D., … [Read more…]